EE505 Predictive Analysis Comparing Economic and Clinical Consequences of Treatment-related Hepatotoxicity in KRASG12C-mutated Advanced Non-small Cell Lung Cancer (aNSCLC) Patients Treated Post-immunotherapy (IO)
Abstract
Authors
S Keeping W Zhang A Berardi W Bouwmeester C Qian S Gao A Vaysman M Laurie B Korytowsky